Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma
Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the biotech industry and the development of peptide-based...
20 Mars 202450min
The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks
Synopsis: In the recent episode of Biotech2050, Ken Galbraith, CEO of Zymeworks, shares profound insights into the biotech industry, leadership, and the complexities of developing innovative treatmen...
13 Mars 202440min
Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis
Synopsis: In this episode of Biotech2050, host Alok Tayi engages in a profound conversation with Craig Chambliss, CEO and co-founder of Neurellis, delving into their strategic advancements in precisi...
6 Mars 202436min
Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics
Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical background to leading innovative gene therapy compa...
28 Feb 202423min
Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge
Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving landscape of aging biology and the innovative approach ...
21 Feb 202426min
The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion
Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of a...
14 Feb 202439min
Psychedelics, Longevity, and Wellbeing, Christian Angermayer, Founder, Apeiron Investment Group
Synopsis: Christian Angermayer, a prominent investor and entrepreneur in the biotech industry, shares valuable insights in the Biotech2050 podcast, shedding light on the challenges and opportunities ...
7 Feb 202446min
Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT
Synopsis: In this episode of the Biotech2050 podcast, David Kirn, CEO of 4D Molecular Therapeutics, shares invaluable insights for aspiring entrepreneurs in the biotech industry. Kirn discusses the d...
31 Jan 202433min
